"North Cell Pharmaceutical, Inc. and GlaxoSmithKline Consumer Healthcare have entered into an Option and Development Agreement regarding North Cell’s Skin Resuscitation FactorTM (SRFTM ) technology for use in certain applications. . ."
for those who have missed this exceptional DD post by BALAMIDAS